PP
TDOC icon

Paloma Partners’s Teladoc Health TDOC Stock Holding History

Paloma Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28,982
Closed -$2.09M – 1733
2022
Q1 		$2.09M Buy
28,982
+4,038
+16% +$291K 0.06% 240
2021
Q4 		$2.29M Sell
24,944
-3,915
-14% -$468K 0.03% 417
2021
Q3 		$3.66M Buy
+28,859
New +$4.2M 0.09% 136
2021
Q2 		– Sell
-13,706
Closed -$2.22M – 2260
2021
Q1 		$2.49M Buy
13,706
+12,872
+1,543% +$2.99M 0.05% 330
2020
Q4 		$167K Sell
834
-6,166
-88% -$1.25M ﹤0.01% 1435
2020
Q3 		$1.53M Sell
7,000
-203,303
-97% -$43.1M 0.04% 489
2020
Q2 		$40.1M Buy
210,303
+204,722
+3,668% +$35.9M 0.7% 9
2020
Q1 		$865K Buy
+5,581
New +$649K 0.05% 325
2019
Q2 		– Sell
-14,400
Closed -$801K – 2160
2019
Q1 		$801K Buy
+14,400
New +$879K 0.02% 837
2017
Q4 		– Sell
-6,304
Closed -$209K – 2279
2017
Q3 		$209K Sell
6,304
-6,253
-50% -$205K ﹤0.01% 1972
2017
Q2 		$436K Buy
+12,557
New +$366K 0.01% 1628

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Paloma Partners's TDOC Position: Q2 2022 in Review

Paloma Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 28,982 shares — an estimated $2.09M sold.

Paloma Partners first reported a position in TDOC in Q2 2017 and held it in 11 quarters. The position peaked at $40.1M in Q2 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Paloma Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 28,982 Teladoc Health shares in Q2 2022, an estimated $2.09M.
  • Paloma Partners first reported a position in Teladoc Health in Q2 2017 and held it in 11 quarters.
  • Paloma Partners's Teladoc Health position peaked at $40.1M in Q2 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.